BEGIN:VCALENDAR
VERSION:2.0
PRODID:Linklings LLC
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
X-LIC-LOCATION:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20241017T183512Z
LOCATION:Harbor Ballrooms D-I
DTSTART;TZID=America/Los_Angeles:20241017T091500
DTEND;TZID=America/Los_Angeles:20241017T093500
UID:ncs_NCS 2024_sess101_ccrnt191@linklings.com
SUMMARY:Updates on Antithrombotics in Acute Neuroendovascular Stenting
DESCRIPTION:Breakout Session\n\nDevin Holden (Albany Medical Center)\n\nIn
 creasingly, neuroendovascular methods are being utilized to manage neurova
 scular abnormalities including acute ischemic stroke and aneurysm repair. 
 Frequently stent placement is necessary during these procedures and patien
 ts may present to the neuro intensive care unit post acute stent placement
 . Acute stent placement necessitates antiplatelet therapy and many centers
  employ some form of platelet function testing. Newer neuroendovascular de
 vices are being developed and the field is constantly changing. Treatment 
 of neuroendovascular patents in the ICU may be complicated  by issues rela
 ted to antiplatelet therapy, platelet function testing and neurovascular c
 omplications. This session aims to inform and educate the intensivist of t
 he latest literature and important points about neuroendovascular patients
  - specifically focused on platelet function testing, updates on antithrom
 botics in acute neuroendovascular stenting and newer devices and potential
  device complications.\n\nTrack: Clinical Practice\n\nFocus Area: Intracer
 ebral Hemorrhage, Ischemic Stroke, Multimodal Neuromonitoring (invasive/no
 n-invasive), Nursing Pharmacology, Pharmacist Practice, Stroke, Subarachno
 id Hemorrhage\n\nTarget Audience: Intermediate\n\nSession Chair: Angela Ha
 ys Shapshak (University of Alabama at Birmingham)
END:VEVENT
END:VCALENDAR
